In vitro and in vivo studies on the complexes of glipizide with water-soluble β-cyclodextrin-epichlorohydrin polymers

Drug Development and Industrial Pharmacy

Volumn 37, Issue 5, 2011, Pages 606-612

  Nie, Shufang ^a,b   Zhang, Shu ^b   Pan, Weisan ^b   Liu, Yanli ^b  

^a Applied Biotechnology Research Center   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

bioavailability; dissolution rate; Glipizide; inclusion complex; water soluble cyclodextrin polymer

Indexed keywords

BETA CYCLODEXTRIN; EPICHLOROHYDRIN; GLIPIZIDE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; EVAPORATION; IN VITRO STUDY; IN VIVO STUDY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANIMALS; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DOGS; DRUG CARRIERS; EPICHLOROHYDRIN; GLIPIZIDE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; POLYMERS; RANDOM ALLOCATION; SOLUBILITY; WATER;

EID: 79953768617     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2010.533277     Document Type: Article

References (29)

1. Adel MA, Mazen KQ, Mahrous OA. (2003). Enhancement of dissolution rate and bioavailability of glipizide through cyclodextrin inclusion complex. Pharm Technol 27:54-62.
2. Bekers O, Uijtendaal EV, Beijnen JH, Buit A, Underberg WJM. (1991). Cyclodextrins in the pharmaceutical field. Drug Dev Ind Pharm 17:1503-1549.
3. Bhosale AV, Hardikar SR, Jagtap RS, Patil NB, Dhawale SS, Shirsath SC. (2009). Formulation of beta cyclodextrin complexed controlled release matrix tablet of glipizide and its in-vitro evaluation. Int J Pharm Tech Res 1:773-778.
4. Duchêne D. (1987). Cyclodextrin and Their Industrial Uses. Editions de Santé, Paris.
5. Fenyvesi E. (1988). Cyclodextrin polymers in the pharmaceutical industry. J Incl Phenom 6:537-545.
6. Gan Y, Pan W, Wei M, Zhang R. (2002). Cyclodextrin complex osmotic tablet for glipizide delivery. Drug Dev Ind Pharm 28:1015-1021.
7. Higuchi T, Connors KA. (1965). Phase-solubility techniques. Adv Anal Chem Instrum 4:117-212.
8. Irie T, Uekama K. (1997). Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci 86:147-162. (Pubitemid 27078377)
9. Khan KA. (1975). The concept of dissolution efficiency. J Pharm Pharmacol 27:48-49.
10. Loftsson T, Brewster ME. (1996). Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 85:1017-1025. (Pubitemid 26338912)
11. Loftsson T, Fridriksdottir H, Sigurdardottir AM. (1994). The effect of water-soluble polymers on drug-cyclodextrin complexation. Int J Pharm 110:169-177. (Pubitemid 24248089)
12. Marcus EB, Roger V, Peeters J, Peter N, Geert V, Thorsteinn L. (2008). Comparative interaction of 2-hydroxypropyl-β-cyclodextrin and sulfobutylether-β-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions. Eur J Pharm Sci 3:494-103.
13. Mura P, Faucci MT, Maestrelli F, Furlanetto S, Pinzauti S. (2002). Characterization of physicochemical properties of naproxen systems with amorphous beta-cyclodextrin-epichlorohydrin polymers. J Pharm Biomed Anal 29:1015-1024. (Pubitemid 34756654)
14. Ozkan Y, Atay T, Dikmen N, Isimer A, Aboul-Enein HY. (2000). Improvement of water solubility and in vitro dissolution rate of gliclazide by complexation with beta-cyclodextrin. Pharm Acta Helv 74:365-370. (Pubitemid 30227321)
15. Peeter J, Neeskens P, Adriaensen J, Brewster M. (2002). Effect of temperature on complexation with 2-hydroxypropyl-β-cyclodextrin. J Incl Phenom Mol 44:75-77.
16. Rajan K, Verma1 SG. (2004). Development and evaluation of osmotically controlled oral drug delivery system of glipizide. Eur J Pharm Biopharm 57:513-525.
17. Rajewski RA, Stella VJ. (1996). Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J Pharm Sci 85:1142-1169.
18. Renard E, Deratani A, Volet G, Sebille B. (1997). Preparation and characterization of water soluble high molecular weight β-cyclodextrin- epichlorohydrin polymers. Eur Polym J 33:49-57. (Pubitemid 127400456)
19. Robert O, Vorapann M, Mongkol S. (1998). Characterization of an inclusion complex of cholesterol and hydroxypropyl-β-cyclodextrin. Eur J Pharm Biopharm 46:355-360.
20. Savolainen J, Jarvinun K, Matilainen L. (1998). Improved dissolution and bioavailability of phenytoin by sulfobutylether-cyclodextrin ((SBE)7m-CD) and hydroxypropyl-β-cyclodextrin (HP-β-CD) complexation. Int J Pharm 165:69-78. (Pubitemid 28218345)
21. Stella VJ, Rajewski RA. (1997). Cyclodextrins: their future in drug formulation and delivery. Pharm Res 14:556-567. (Pubitemid 27220271)
22. Szejtli J. (1994). Medicinal applications of cyclodextrins. Med Res Rev 14:353-386. (Pubitemid 24142073)
23. Szeman J, Ueda H, Szejtli J, Fenyvesi E, Machida Y, Nagai T. (1987). Complexation of several drugs with water-soluble cyclodextrin polymer. Chem Pharm Bull 35:282-288. (Pubitemid 17021393)
24. Szente L, Szejtli J. (1999). Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development. Adv Drug Deliv Rev 36:17-28. (Pubitemid 29074474)
25. Tan FP, Jiang TM, Jiang GQ. (2004). Preparation and physicochemical properties of glipizide-β-cyclodextrin inclusion complex. Fine Chemicals 21:191-194.
26. Thompson DO. (1997). Cyclodextrins-enabling excipients: their present and future use in pharmaceuticals. Crit Rev Ther Drug Carrier Syst 14:1-104. (Pubitemid 27079973)
27. Uekama K, Otagiri M, Irie T, Seo H, Tsuruoka M. (1985). Improvement of dissolution and absorption characteristics of phenytoin by a water-soluble cyclodextrin-epichlorohydrin polymer. Int J Pharm 23:35-42. (Pubitemid 15159580)
28. Ventura VA, Tirendi S, Puglisi G, Bousquet E. (1997). Improvement of water solubility and dissolution rate of ursodeoxychilic acid and chenodeoxychilic acid by complexation with natural and modified cyclodextrins. Int J Pharm 149:1-13. (Pubitemid 27193414)
29. Zhang YM, Li X, Sun CS, Chen CF. (2008). The study on the preparation and spectroscopic properties of hydroxypropyl-beta-cyclodextrin/glipizide inclusion complex. Guang Pu Xue Yu Guang Pu Fen Xi 28:711-714. (Pubitemid 351617175)